MarketInOut Stock Screener Log In | Sign Up

CORONA Remedies Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
CORONA Remedies Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization135,473 mln
Float13.38 mln
Earnings Date10/30/2026

EPS

32.54
Stretched

P / E

66.59
Richly valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.27
Borderline

Relative Strength

92 / 100
Top performer

Debt / Equity

0.22
Very low leverage

Business Description

Founded in 2004 and headquartered in Ahmedabad, India, CORONA Remedies Limited creates and sells a wide range of medicines across multiple health conditions. The company serves patients dealing with heart disease, diabetes, respiratory issues, digestive problems, and several other medical needs, with a particular focus on women's health.

Key Fundamentals

EPS32.54
P/E66.59
ROE29.59
RPS242
ROIC24.28
ROA18.82
Interest Cover35.85
EBITDA, mln3,094
EV / EBITDA40.74
EV / EBIT47.17
Revenue, mln14,791
EV / Revenue8.52

Quote Details

Last 2,166.90
Change -48 (-2.17%)
Open 2,218.05
Volume 1,269
Turnover 2,749,796
Average Volume 3,874

Financial Ratios

Pre-Tax Profit Margin18
Current Ratio0.96
Price / Book17.62
Price / Tangible Book27.19
Price / Free Cash Flow230
Debt / Equity0.22
Price / Sales8.90

Financial Strength

Altman Z-Score17.94
Piotroski F-Score 8 / 9
Beneish M-Score-2.27
Price to Graham Number8.95

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.06% 86 / 100   
1 Month 4.01% 87 / 100   
2 Months 6.8% 79 / 100   
6 Months 29.04% 87 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog